Journal Article

The Best Approach to Reintroducing Tuberculosis Treatment after Hepatotoxicity Is Still Open to Debate

Kwok Chiu Chang and Chi Chiu Leung

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 51, issue 3, pages 366-367
Published in print August 2010 | ISSN: 1058-4838
Published online August 2010 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/654806
The Best Approach to Reintroducing Tuberculosis Treatment after Hepatotoxicity Is Still Open to Debate

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

To the Editor—The best approach of reintroducing tuberculosis drugs after hepatotoxicity is still open to debate. Sharma et al [1] suggested that simultaneous reintroduction of isoniazid, rifampin, and pyrazinamide after drug-induced hepatotoxicity did not yield statistically significantly different results from sequential reintroduction with regard to the risk of recurrent hepatotoxicity. An editorial attempted to attribute the negative finding to mere hepatic adaptation or incidental liver function derangement for many of the initial events and to noncompliance during reintroduction [2]. We would like to share slightly different views in the interpretation of the findings.

Journal Article.  602 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.